First Time Loading...

Venus Medtech Hangzhou Inc
HKEX:2500

Watchlist Manager
Venus Medtech Hangzhou Inc Logo
Venus Medtech Hangzhou Inc
HKEX:2500
Watchlist
Price: 5.62 HKD Market Closed
Updated: May 3, 2024

Venus Medtech Hangzhou Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Venus Medtech Hangzhou Inc
Cash from Financing Activities Peer Comparison

Comparables:
A
688617
J
002223
300760
L
300003
688271

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Venus Medtech Hangzhou Inc
HKEX:2500
Cash from Financing Activities
¥635.1m
CAGR 3-Years
-37%
CAGR 5-Years
30%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash from Financing Activities
-¥246.4m
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash from Financing Activities
-¥1B
CAGR 3-Years
N/A
CAGR 5-Years
-57%
CAGR 10-Years
-34%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash from Financing Activities
-¥5.2B
CAGR 3-Years
-61%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Cash from Financing Activities
-¥332.2m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
-7%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash from Financing Activities
¥10.7B
CAGR 3-Years
242%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Venus Medtech Hangzhou Inc's Cash from Financing Activities?
Cash from Financing Activities
635.1m CNY

Based on the financial report for Dec 31, 2022, Venus Medtech Hangzhou Inc's Cash from Financing Activities amounts to 635.1m CNY.

What is Venus Medtech Hangzhou Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
30%

Over the last year, the Cash from Financing Activities growth was -54%. The average annual Cash from Financing Activities growth rates for Venus Medtech Hangzhou Inc have been -37% over the past three years , 30% over the past five years .